Alluvi supplies Retatrutide pens exclusively for laboratory research and development
Patients with renal impairment may have higher plasma concentrations than those with normal function
Because retatrutide is newer than tirzepatide and semaglutide , the Canadian supplier market for it is less mature, and pricing varies more widely than for older peptides
Tirzepatide injection (is $289/mo month-to-month (or $249/mo on the 6-month plan)) reaches the bloodstream directly and typically produces stronger appetite suppression with faster onset, while oral tirzepatide (is $349/mo month-to-month (or $279/mo on the 6-month plan)) is absorbed through the digestive tract and may cause less intense nausea for some patients
The rapid expansion of the market is primarily attributed to the increasing prevalence of type 2 diabetes and obesity, a growing aging population, changing lifestyle patterns, and the continuous development of advanced GLP-1 formulations, including oral therapies and long-acting injectable drugs
When patients complete the Precision Peptide Genetic Test, PlexusDx uses those insights to inform medication selection and dosing recommendations
.jpg)
